Back

Tauropace reduces infections in patients with heart failure and reduced ejection fraction after cardiac electronic implantable device implantation.

1 April 2025 (10:30 - 11:15)
Organised by: Logo
Congress Presentation Part of: Device complications and lead extraction Device Complications and Lead Extraction EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Daniele Faccenda

Istituto Cardiocentro Ticino, Lugan (Switzerland)

6 More presentations in this session

Presentation thumbnail
Multicentric experience with the use of short 13Fr bidirectional mechanical rotating dilator sheath for transvenous lead extraction
Doctor A. Preda (Milan, IT)
Abstract Slides Video
Presentation thumbnail
The risk of failure of subcutaneous implantable cardioverter defibrillator therapy: from PRAETORIAN score to clinical practice
Doctor M. Ziacchi (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
The no-cut technique for lead preparation in transvenous lead extraction: a preliminary single centre experience
Doctor M. Baroni (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Extraction of novel, small diameter OmniaSecure defibrillation lead from the deep septum in sheep
Mrs M. Upchurch (Minneapolis, US)
Abstract Slides Video
Presentation thumbnail
Retrospective observational study of tricuspid regurgitation in patients with device implantation (PM, CRT) in LBBP Position
Assistant Professor G. Leventopoulos (Patras, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Device complications and lead extraction

The Event

Event poster

EHRA 2025

1 April 2025 10:30 CET
You may be interested in
thumbnail
Congress Presentation
Impact of taurolidine use during cardiac electronic implantable device implantation in heart failure patients
thumbnail
Congress Presentation
Postoperative antibiotic prophylaxis following cardiac implantable electronic device implantation and the risk of device infection
thumbnail
Congress Presentation
Efficacy of drug eluting envelopes in reducing infections among pacemaker patients: the REINFORCE real-world data project

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources